- Home
- ADBE vs BSX Comparison
ADBE vs BSX Comparison
Compare ADBE & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADBE | BSX |
|---|---|---|
| Founded | 1982 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.0B | 149.7B |
| IPO Year | 1986 | 1992 |
Fundamental Metrics
Financial Performance| Metric | ADBE | BSX |
|---|---|---|
| Price | $355.94 | $92.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 24 | 19 |
| Target Price | ★ $440.82 | $124.53 |
| AVG Volume (30 Days) | 4.3M | ★ 9.7M |
| Earning Date | 12-10-2025 | 10-22-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 35.11 | ★ 54.68 |
| EPS | ★ 16.70 | 1.87 |
| Revenue | ★ $23,769,000,000.00 | $19,349,000,000.00 |
| Revenue This Year | $11.10 | $21.05 |
| Revenue Next Year | $9.18 | $11.43 |
| P/E Ratio | ★ $21.34 | $49.51 |
| Revenue Growth | 10.53 | ★ 21.61 |
| 52 Week Low | $311.59 | $85.98 |
| 52 Week High | $494.00 | $109.50 |
Technical Indicators
Market Signals| Indicator | ADBE | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 66.60 | 33.35 |
| Support Level | $333.79 | $91.45 |
| Resistance Level | $348.59 | $93.89 |
| Average True Range (ATR) | 9.83 | 2.10 |
| MACD | 4.21 | -0.83 |
| Stochastic Oscillator | 87.25 | 10.42 |
Price Performance
Historical ComparisonAbout ADBE Adobe Inc.
Adobe provides content creation, document management, and digital marketing and advertising software and services to creative professionals and marketers for creating, managing, delivering, measuring, optimizing, and engaging with compelling content multiple operating systems, devices, and media. The company operates with three segments: digital media content creation, digital experience for marketing solutions, and publishing for legacy products (less than 5% of revenue).
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.